focus -WSS

focus

author：entertainment 2025-09-06 02:13:49 - browse：3

Pfizer and Moderna aren’t the only vaccine money-makers. Much of the revenue and profits from Covid-19 vaccines are flowing behind the scenes, going to the contract manufacturers and clinical-trial organizers that turn the shots from lab-bench theory to mass-produced reality.

Both AstraZeneca and Johnson & Johnson publicly committed to not profiting off their products during the pandemic — though AstraZeneca has reserved the right to declare the pandemic over on July 1, even if the World Health Organization has not. Pfizer and Moderna made no such pledge, with Pfizer expected to make $15 billion in vaccine-related revenue this year, while Moderna is forecasting $18.4 billion in vaccine sales.

Contractors hired to test and manufacture these vaccines have enjoyed a share of the profits without the same level of public scrutiny.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： New weight loss drugs vying to be the next Wegovy or Mounjaro

Wikipedia

WSS

New weight loss drugs vying to be the next Wegovy or Mounjaro

PEPFAR is under serious threat — and so is global health

Abortion pill case raises question: who can sue the FDA?

Acelyrin, a rare IPO success, stumbles in its first big test

Abortion pill Supreme Court ruling could impact entire drug industry

WATCH: Why do bright lights make us see spots?

focus

focus

focus

Tori Bowie and the unacceptable rates of Black maternal death

Donor acceptance rates hint at racial, gender bias in heart transplants: study

How one medical school became remarkably diverse

Will the IRA bring competition to the biologics market?

As demand for Covid shots wanes, Moderna seeks its next success

Washington mulls new rules to avert another Change Healthcare

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Jerome Adams on the need for new antivirals for Covid

The Readout: Lenmeldy, GLP

focus

Donor acceptance rates hint at racial, gender bias in heart transplants: study

FDA approves updated Covid vaccines

Food as medicine: Medically tailored meals may get standardized

Scientists boost immune system in aging mice by making it youthful

Abortion pill case raises question: who can sue the FDA?

There's no autism epidemic. It's an autism diagnosis epidemic

Wikipedia

explore

Wikipedia

entertainment